The Department of Surgery at the University of Texas Medical School at Houston
Department of Surgery
Scott C. Holmes

Scott C. Holmes

Director of Graphic Services
  Medical Illustrator
  Website Coordinator


Biography

Scott HolmesScott Holmes graduated with a major in Medical Illustration from a joint program at the Cleveland Institute of Art and Case Western Reserve University in 1995. That same year he began work at Medical Plastics Lab (Now Laerdal) in Gatesville, Texas. There, he designed anatomical models, CPR manikins and simulators such as the Neonatal Resuscitation Baby and Femoral Access Trainer as well as creating traditional illustrations for MPL's literature. In 1997 he received his certification as an Emergency Medical Technician.
In 1999, Scott joined the Division of Immunology and Organ Transplantation. He continues to work with a wide range of applications including surgical illustration, copy editing, web design, graphic design, scientific illustration, animation and preparations of manuscripts, grants and award winning presentations and posters. In July of 2006, the role of Director of Graphic Services for the Department of Surgery was added to his duties. In 2007 and 2008 the Departments of Pediatric Surgery as well as Pathology & Laboratory Medicine were added, respectively. 2009 marks the beginning of his work for the Center for Translational Injury Research (CeTIR).

Publication:
Abstract

DY Liu, S Holmes, Z Kaposztas, R Zhang, J Yuan, AZ. Luo, MR Blackburn, AD Kulkarni, F Thomson, CT Van Buren. Topical Application of Nucleotides Does Not Affect Wound Healing in CD73 Knockout Mice. 31st ESPEN Congress on Clinical Nutrition and Metabolism, in Vienna, Austria. Clin Nutrition; 4(Sup 2):173, 2009 (View Poster)

Editor

The Phoenix Newsletter 2008-present

Editorial / Graphics Acknowledgements:
  1. Hong JC, and Kahan BD: A calcineurin antagonist-free induction immunosuppression strategy for delayed graft function in renal transplantation. Transplant. Proc. 33:1271-1272, 2001. 
  2. Kahan BD, and Camardo JS: Rapamycin: Clinical results and future opportunities. Transplantation. 72:1181-1193, 2001.
  3. Kahan BD: Sirolimus: A comprehensive review. Expert Opin. Pharmacother. 2:1903-1917, 2001.
  4. Stepkowski SM, Erwin-Cohen RA, Behbod F, Wang ME, Qu X, Tejpal N, Nagy ZS, Kahan BD, and Kirken RA: Selective inhibitor of janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin. Blood. 99:680-689, 2002.
  5. Chueh S-C J, and Kahan BD: Update on FTY720: review of mechanisms and clinical results. Curr. Opin. Organ Transplant. 8:288-298, 2003.
  6. Podder H, and Kahan BD: Janus kinase 3 (Jak3): a novel target for transplant immunosuppression. Expert Opin. Ther. Targets. 8:613-639, 2004.
  7. The Digital Biomedical Illustration Handbook Mike de la Flor, Charles River Media 2004.
  8. Kahan BD, and Napoli KL: Sirolimus. In: Burton, M.E., et al. (eds.): Pharmacokinetics and pharmacodynamics: Principles of therapeutic drug monitoring, Fourth edition. Lippincott, Williams & Wilkins, 595-616. 2005.
  9. Stepkowski SM, Kao J, Wang, M.E., Tejpal N, Podder H, Furian L, Dimmock J, Jha A, Das U, Kahan BD, and Kirken RA: The Mannich base NC1153 promotes long-term allograft survival and spares the recipient from multiple toxicities. J. Immunol. 175:4236-4246, 2005.
  10. Shi-Zhong Luo, Xi Mo, Vahid Afshar-Kharghan, Sankaranarayanan Srinivasan, José A. López, and Renhao Li: Glycoprotein Ib-α forms disulfide bonds with 2 glycoprotein Ib-β subunits in the resting platelet. Blood; 109:603-609, 2007.
  11. Kobayashi K, Censullo ML, Rossman LL, Kyriakides PN, Kahan BD, Cohen AM: Interventional radiologic management of renal transplant dysfunction: indications, limitations, and technical considerations. Radiographics;27(4):1109-30, 2007.
  12. Stepkowski SM, Chen W, Ross JA, Nagy ZS, Kirken RA: STAT3: an important regulator of multiple cytokine functions.Transplantation;85(10):1372-7, 2008.
  13. Kahan BD: Podbielski J, Childs B. The impact of conversion from mycophenolate mofetil to mycophenolate sodium among renal transplant recipients on a sirolimus-based regimen. Transplant Proc; 40(5):1429-34, 2008.
  14. Kahan BD:. Frontiers in Immunosuppression. Transplant Proc; 40(1):11-15, 2008.
  15. Kahan BD: Fifteen Years of Clinical Studies and Clinical Practice in Renal Transplantation: Reviewing Outcomes With De Novo Use of Sirolimus in Combination With Cyclosporine.Transplant Proc; 40(10 Suppl):S17-20, 2008.
  16. Kaposztas Z, Podder H, Mauiyyedi S, Illoh O, Kerman RH, Reyes M, Pollard V and Kahan BD: Impact of rituximab therapy for treatment of acute humoral rejection. Clin Transplant; 23(1):63-73, 2009.
  17. Poster: Emmanouil Tsounias, Monesha Gupta-Malhotra, Georgios A. Hartas, Mohammed Numan, Felix W. Tsai. Cor Triatriatum Sinister with Persistent Left Superior Vena Cava and Dilated Coronary Sinus: A Novel Management Approach. 5th World Congress of Paediatric Cardiology and Cardiac Surgery, Cairns, Australia.
  18. Poster: A.M. Zaske, D. Danila, Michael C. Queen, E. Golunski, Jodie L. Conyers, "Using Biological AFM to Image Gold-labeled Liposomes at Human Coronary Endothelial Cell (HCAEC) Membranes," Veeco: Seeing the Nanoscale VII, July 2009.

Scott is a professional member of the Association of Medical Illustrators.

certificate

Contact Information:

Tel: 713-500-7358

Email: Scott.Holmes@uth.tmc.edu